Shaperon   Report issue

For profit Phase 2
Founded: Gangnam Korea, Republic of (2013)

Organization Overview

First Clinical Trial
2018
NCT03492398
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Shaperon | Shaperon Inc.